Earnings Feed
Start Free
Home/Filings/4/A/0000947871-11-000037
4/A//SEC Filing

SUN PHARMA GLOBAL INC 4/A

Accession 0000947871-11-000037

CIK 0000906338other
View on SEC.govCompany Profile

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 5:33 PM ET

Size

28.6 KB

Accession

0000947871-11-000037

Insider Transaction Report

Form 4/AAmended
Period: 2011-01-18
TARO PHARMACEUTICAL INDUSTRIES LTDTAROF
SUN PHARMACEUTICAL INDUSTRIES LTD
10% OwnerOther
Transactions
  • Conversion

    Warrant (right to buy)

    2011-01-18$6.00/sh−712,500$4,275,000→ 0 total(indirect: Alkaloida Chemical Company Exclusive Group Ltd.)
    Exercise: $6.00From: 2007-08-01Exp: 2010-05-18→ Ordinary Shares (712,500 underlying)
  • Conversion

    Restricted Shares

    2011-01-18$6.00/sh+712,500$4,275,000→ 15,210,433 total(indirect: Alkaloida Chemical Company Exclusive Group Ltd.)
    Exercise: $6.00→ Ordinary Shares (712,500 underlying)
  • Conversion

    Restricted Shares

    2011-01-18$6.00/sh+712,500$4,275,000→ 15,922,933 total(indirect: Alkaloida Chemical Company Exclusive Group Ltd.)
    Exercise: $6.00From: 2007-08-01→ Ordinary Shares (712,500 underlying)
SUN PHARMA GLOBAL INC
10% OwnerOther
Transactions
  • Conversion

    Warrant (right to buy)

    2011-01-18$6.00/sh−712,500$4,275,000→ 0 total(indirect: Alkaloida Chemical Company Exclusive Group Ltd.)
    Exercise: $6.00From: 2007-08-01Exp: 2010-05-18→ Ordinary Shares (712,500 underlying)
  • Conversion

    Restricted Shares

    2011-01-18$6.00/sh+712,500$4,275,000→ 15,210,433 total(indirect: Alkaloida Chemical Company Exclusive Group Ltd.)
    Exercise: $6.00→ Ordinary Shares (712,500 underlying)
  • Conversion

    Restricted Shares

    2011-01-18$6.00/sh+712,500$4,275,000→ 15,922,933 total(indirect: Alkaloida Chemical Company Exclusive Group Ltd.)
    Exercise: $6.00From: 2007-08-01→ Ordinary Shares (712,500 underlying)
Alkaloida Chemical CO Exclusive Group Ltd.
10% OwnerOther
Transactions
  • Conversion

    Warrant (right to buy)

    2011-01-18$6.00/sh−712,500$4,275,000→ 0 total(indirect: Alkaloida Chemical Company Exclusive Group Ltd.)
    Exercise: $6.00From: 2007-08-01Exp: 2010-05-18→ Ordinary Shares (712,500 underlying)
  • Conversion

    Restricted Shares

    2011-01-18$6.00/sh+712,500$4,275,000→ 15,210,433 total(indirect: Alkaloida Chemical Company Exclusive Group Ltd.)
    Exercise: $6.00→ Ordinary Shares (712,500 underlying)
  • Conversion

    Restricted Shares

    2011-01-18$6.00/sh+712,500$4,275,000→ 15,922,933 total(indirect: Alkaloida Chemical Company Exclusive Group Ltd.)
    Exercise: $6.00From: 2007-08-01→ Ordinary Shares (712,500 underlying)
Footnotes (6)
  • [F1]No date exercisable. The Ordinary Shares were purchased pursuant to the share purchase agreement dated May 18, 2007 (the "Purchase Agreement"), between Alkaloida Chemical Company Exclusive Group Ltd. ("Alkaloida"), an indirect subsidiary of Sun Pharmaceutical Industries Ltd. ("Sun"), and Taro Pharmaceutical Industries Ltd. (the "Issuer").
  • [F2]No expiration date.
  • [F3]This amount represents 58,000 Ordinary Shares acquired by Sun Pharma Global, Inc. ("Sun Pharma"), a direct wholly-owned subsidiary of Sun, on July 7, 2007 and 500 Ordinary Shares acquired by Sun Pharma on July 23, 2007, in each case in open market transactions; 3,712,557 Ordinary Shares acquired by Alkaloida, on February 19, 2008 and 797,870 Ordinary Shares acquired by Alkaloida on June 23, 2008, in each case in a private transaction; 29,382 Ordinary Shares acquired by Alkaloida on September 14, 2010 upon the expiration of its tender offer to acquire all of Issuer's outstanding Ordinary Shares; and 2,405,937 Ordinary Shares acquired by Alkaloida pursuant to a letter agreement dated September 20, 2010.
  • [F4]This amount also includes 2,333,922 Ordinary Shares indirectly acquired by Sun Pharmaceutical Industries Inc. ("Sun Michigan"), a Michigan corporation and a direct subsidiary of Sun, through a merger of a subsidiary of Sun Michigan with and into The Taro Development Corporation on October 1, 2010; and 5,159,765 Ordinary Shares acquired by Alkaloida on November 1, 2010 from Franklin Advisors, Inc. and Templeton Asset Management Ltd in a private transaction.
  • [F5]In addition, Sun indirectly owns 14,287,500 Ordinary Shares which are restricted stock consisting of: (i) 3,770,833 Ordinary Shares acquired by Alkaloida on May 21, 2007, 3,016,667 Ordinary Shares acquired by Alkaloida on May 30, 2007 and 712,500 Ordinary Shares acquired by Alkaloida on January 18, 2011, in each case pursuant to the Purchase Agreement; (ii) 3,000,000 Ordinary Shares acquired by Alkaloida on August 2, 2007, pursuant to Sun's rights under the warrant, dated May 18, 2007, issued by the Issuer to Sun ("Warrant No. 2"), and (iii) 3,712,500 Ordinary Shares acquired by Alkaloida on September 24, 2010 and 75,000 Ordinary Shares acquired by Alkaloida on September 27, 2010, in each case pursuant to a warrant dated August 2, 2007, between Sun and the Issuer.
  • [F6]This amount also includes 712,500 Ordinary Shares acquired by Alkaloida on January 18, 2011, pursuant to Warrant No. 2.

Documents

2 files

Issuer

TARO PHARMACEUTICAL INDUSTRIES LTD

CIK 0000906338

→
Entity typeother

Related Parties

1
  • filerCIK 0001197088

Filing Metadata

Form type
4/A
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 5:33 PM ET
Size
28.6 KB
View on SEC.gov